Data Management Core: Systems Biology to Identify Biomarkers of Neonatal Vaccine Immunogenicity
数据管理核心:识别新生儿疫苗免疫原性生物标志物的系统生物学
基本信息
- 批准号:10063820
- 负责人:
- 金额:$ 24.55万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-12-27 至 2023-11-30
- 项目状态:已结题
- 来源:
- 关键词:AgeArchitectureArchivesAtlasesBiologicalBiological MarkersBiometryClinicalClinical DataClinical ServicesCollaborationsCommunitiesComputer softwareConsultationsDataData FilesData SourcesData Storage and RetrievalDatabase and Analysis PortalEnvironmentExperimental DesignsFosteringGene ExpressionGoalsGuidelinesHumanHuman ResourcesImmuneImmunizationImmunologyIn VitroInfrastructureInstitutionInvestigationLeadLifeLinkMetadataMethodsNeonatalNewborn InfantPeptidesPersonnel StaffingPhenotypePlasmaProcessProductivityProteinsProteomicsResearchResearch PersonnelResearch SupportSecureSecurityServicesSignal TransductionSiteSystemSystems AnalysisSystems BiologyUnited States National Institutes of HealthVaccinationVaccinesVariantWorkanalytical toolarchive dataarchived databasebioinformatics infrastructurebioinformatics toolcloud basedcloud storagecomputerized toolscomputing resourcesdata accessdata acquisitiondata infrastructuredata integrationdata managementdata sharingdata toolsdemographicsdesigndigitalexperimental studyheterogenous datahigh riskimmunogenicityinfection riskinsightoperationpredictive signatureprogramspublic repositoryquality assurancerelational databaserepositoryresponsesuccesssynergismtranscriptome sequencingtranscriptomicsweb services
项目摘要
PROJECT SUMMARY
The overarching goal of the proposed Human Immunology Project Consortium (HIPC) is to characterize
vaccine-induced biological variations (transcriptomic/proteomic; summarized as ‘OMIC’) in the human newborn
that correlate with downstream immunogenicity as predictors for Correlates of Protection (CoPs). The Data
Management Core (DMC) will establish and maintain a cloud-based discovery environment, consisting of data
storage and computational tools to perform integrative systems analyses and facilitate collaborations between
the HIPC Projects and Cores. The DMC will also facilitate data sharing, submission to public repositories, and
HIPC engagement with the external research community. The broad goals of the DMC are reliable data
capture and retention; ongoing quality assurance; and provision of access/computational resources for
integrative analyses. We articulate these goals through three Specific Aims:
Aim 1: Create a secure data management infrastructure for data acquisition and retention from HIPC Clinical
Core Sites, Service Cores, and Projects.
Aim 2: Establish HIPC-wide quality assurance processes and accepted standards for each of the
heterogeneous data sources.
Aim 3: Provide biostatistical and bioinformatics tools and expertise to lead integrative analyses across
platforms.
Our data management architecture will rely on new capabilities at our institution to access Amazon Web
Services (AWS) for reliable cloud-based research support. We have worked closely with our Research
Computing department to implement a system for HIPC collaborators that will combine security and reliability
with ease of access and the most advanced computational tools and resources available. We believe our
approach will offer many advantages over a more traditional server-based architecture, not the least of which is
a more fruitful computing environment for integrative analyses and scientific discovery.
Scientific endeavors of this scope/scale require robust data management plans, infrastructure, and operations.
Practical data integration requires an environment within which these data can be linked across platforms. The
DMC’s function will build on close integration of project/core leads into the DMC (eg, Drs. Steen, Tebbutt,
Brinkman, Foster and Hancock) thereby synergistically leveraging their distinct strengths and augmenting the
the productivity and impact of our proposed program. Completion of our Specific Aims will enable fresh insights
into the biological basis underlying vaccine protective responses in early life, informing rational design of
effective vaccines for the very young who are at highest risk from infections.
项目摘要
拟议的人类免疫学项目联盟(HIPC)的总体目标是表征
人类新生儿中疫苗诱导的生物学变异(转录组/蛋白质组学;总结为“ Omic”)
这与下游免疫原性相关,作为保护相关的预测因子(COPS)。数据
管理核心(DMC)将建立并维护基于云的发现环境,由数据组成
存储和计算工具,以执行集成系统分析并促进合作
HIPC项目和核心。 DMC还将促进数据共享,提交给公共存储库以及
HIPC与外部研究社区的互动。 DMC的广泛目标是可靠的数据
捕获和保留;持续的质量保证;并为访问/计算资源提供
综合分析。我们通过三个具体目标来表达这些目标:
目标1:创建一个安全的数据管理基础架构,以从HIPC临床中获取和保留数据
核心站点,服务核心和项目。
目标2:建立HIPC范围内的质量保证过程和公认的标准
异构数据源。
目标3:提供生物统计学和生物信息学工具和专业知识,以领导跨越综合分析
平台。
我们的数据管理体系结构将依靠我们机构的新功能来访问Amazon Web
服务(AWS),用于可靠的基于云的研究支持。我们与研究紧密合作
计算部门为HIPC合作者实施系统,以结合安全性和可靠性
易于访问和最先进的计算工具和资源。我们相信我们的
方法将提供比基于服务器基于服务器的架构的许多优势,其中最重要的是
一个更富有成果的计算环境,用于综合分析和科学发现。
这项范围/量表的科学努力需要强大的数据管理计划,基础架构和运营。
实用数据集成需要一个环境,可以使这些数据可以跨平台链接。这
DMC的函数将基于将项目/核心导线密切集成到DMC的基础上(例如
Brinkman,Foster和Hancock)从而协同利用其独特的优势并增强
我们提议的计划的生产力和影响。完成我们的特定目标将使新见解
成为生物基础疫苗的生物基础,以保护早期的反应,从而为理性设计提供
感染风险最高的年轻人的有效疫苗。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
AL OZONOFF其他文献
AL OZONOFF的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('AL OZONOFF', 18)}}的其他基金
Data Management & Analysis Core: IDEAL shapes vaccine response, susceptibility to respiratory infectious disease and asthma
数据管理
- 批准号:
10435037 - 财政年份:2022
- 资助金额:
$ 24.55万 - 项目类别:
Data Management & Analysis Core: IDEAL shapes vaccine response, susceptibility to respiratory infectious disease and asthma
数据管理
- 批准号:
10589803 - 财政年份:2022
- 资助金额:
$ 24.55万 - 项目类别:
Data Management Core: Systems Biology to Identify Biomarkers of Neonatal Vaccine Immunogenicity
数据管理核心:识别新生儿疫苗免疫原性生物标志物的系统生物学
- 批准号:
10344008 - 财政年份:2021
- 资助金额:
$ 24.55万 - 项目类别:
Data Management Core: Systems Biology to Identify Biomarkers of Neonatal Vaccine Immunogenicity
数据管理核心:识别新生儿疫苗免疫原性生物标志物的系统生物学
- 批准号:
10312046 - 财政年份:2021
- 资助金额:
$ 24.55万 - 项目类别:
Improving Syndromic Surveillance by Data Integration
通过数据集成改进症状监测
- 批准号:
7098641 - 财政年份:2006
- 资助金额:
$ 24.55万 - 项目类别:
Improving Syndromic Surveillance by Data Integration
通过数据集成改进症状监测
- 批准号:
7351841 - 财政年份:2006
- 资助金额:
$ 24.55万 - 项目类别:
相似国自然基金
“共享建筑学”的时空要素及表达体系研究
- 批准号:
- 批准年份:2019
- 资助金额:63 万元
- 项目类别:面上项目
基于城市空间日常效率的普通建筑更新设计策略研究
- 批准号:51778419
- 批准年份:2017
- 资助金额:61.0 万元
- 项目类别:面上项目
宜居环境的整体建筑学研究
- 批准号:51278108
- 批准年份:2012
- 资助金额:68.0 万元
- 项目类别:面上项目
The formation and evolution of planetary systems in dense star clusters
- 批准号:11043007
- 批准年份:2010
- 资助金额:10.0 万元
- 项目类别:专项基金项目
新型钒氧化物纳米组装结构在智能节能领域的应用
- 批准号:20801051
- 批准年份:2008
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Survival genetics methods for detecting sex-dependent genetic effects on Alzheimer’s disease
用于检测阿尔茨海默病性别依赖性遗传效应的生存遗传学方法
- 批准号:
10670493 - 财政年份:2022
- 资助金额:
$ 24.55万 - 项目类别:
Efficient methods for genome-wide survival analysis of early childhood caries
儿童早期龋齿全基因组生存分析的有效方法
- 批准号:
10696112 - 财政年份:2022
- 资助金额:
$ 24.55万 - 项目类别:
Optimization and validation of quantitative birefringence microscopy for assessment of myelin pathologies associated with cognitive impairments and motor deficits in young and old aging monkey brain
定量双折射显微镜的优化和验证,用于评估与年轻和年老猴脑认知障碍和运动缺陷相关的髓磷脂病理学
- 批准号:
10544518 - 财政年份:2022
- 资助金额:
$ 24.55万 - 项目类别:
Optimization and validation of quantitative birefringence microscopy for assessment of myelin pathologies associated with cognitive impairments and motor deficits in young and old aging monkey brain
定量双折射显微镜的优化和验证,用于评估与年轻和年老猴脑认知障碍和运动缺陷相关的髓磷脂病理学
- 批准号:
10369974 - 财政年份:2022
- 资助金额:
$ 24.55万 - 项目类别: